CGTX•benzinga•
Chardan Capital Maintains Buy on Cognition Therapeutics, Lowers Price Target to $4
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 8, 2025 by benzinga